{"id":"W4417198347","doi":"10.1200/jco-25-02600","title":"HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Hospital","funders":"","keywords":"Pertuzumab; Trastuzumab; Metastatic breast cancer; Placebo; Maintenance therapy; Phases of clinical research; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001710535,0.001340068,0.002350099,0.0006214852,0.0003697928,0.001076048,0.001082459,0.001367953,0.004119858],"category_scores_gemma":[0.001099654,0.0005422904,0.001225043,0.000455401,0.001006368,0.0009150059,0.00034906,0.002340968,0.0008139334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008245053,"about_ca_system_score_gemma":0.001221105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009777881,"about_ca_topic_score_gemma":0.002881863,"domain_scores_codex":[0.9994911,0.0002765874,0.00002780992,0.00007495414,0.00004866435,0.00008098324],"domain_scores_gemma":[0.999449,0.0001000579,0.0001250276,0.0000286271,0.00002767846,0.0002697233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9384821,0.0177618,0.0008484661,0.0006443182,0.0007998387,0.0000517027,0.00006742595,0.0005518016,0.006634818,0.0001426451,0.001027725,0.03298744],"study_design_scores_gemma":[0.7648094,0.2290927,0.002796244,0.00003588471,0.0004570357,0.00007389211,0.00002905024,0.0007320979,0.001065542,0.0001091411,0.0007807492,0.00001832181],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881391,0.005475481,0.00048336,0.0004396954,0.0003217753,0.002174758,0.0008172432,0.0001721886,0.00197637],"genre_scores_gemma":[0.9916539,0.002428054,0.0007368864,0.0004695433,0.0002833669,0.001725244,0.0007115121,0.00001559379,0.001975963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004119858,"threshold_uncertainty_score":0.01378226,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1733979768876252,"score_gpt":0.5582290306535705,"score_spread":0.3848310537659453,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}